Premium
The impact of national guidelines on venom immunotherapy practice in the United Kingdom
Author(s) -
Diwakar L.,
Ewan P.,
Huber P. A. J.,
Clark A.,
Nasser S.,
Krishna M. T.
Publication year - 2016
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.12728
Subject(s) - medicine , family medicine , guideline , allergy , pediatrics , immunology , pathology
Venom immunotherapy (VIT) is the only effective treatment for prevention of further anaphylactic reactions to bee and wasp stings in allergic individuals. A previous national survey carried out in 2006/2007 revealed significant heterogeneity in UK practice 1. The British Society for Allergy and Clinical Immunology (BSACI) guidelines for the diagnosis and management of hymenoptera venom (HV) allergy were subsequently published in 2011 2 (Table 1).Table 1Results of the VIT UK national surveysThis repeat survey was carried out to assess whether publication of BSACI guidelines helped improve the diagnosis and management of HV allergy in the UK National Health Service (NHS).